Reprogramming non-human primate somatic cells into functional neuronal cells by defined factors by Zhi Zhou et al.
Zhou et al. Molecular Brain 2014, 7:24
http://www.molecularbrain.com/content/7/1/24RESEARCH Open AccessReprogramming non-human primate somatic
cells into functional neuronal cells by defined
factors
Zhi Zhou1, Kazuhisa Kohda1, Keiji Ibata1, Jun Kohyama1, Wado Akamatsu1, Michisuke Yuzaki1,
Hirotaka James Okano2, Erika Sasaki1,3 and Hideyuki Okano1*Abstract
Background: The common marmoset (Callithrix jacchus) is a New World primate sharing many similarities with
humans. Recently developed technology for generating transgenic marmosets has opened new avenues for faithful
recapitulation of human diseases, which could not be achieved in rodent models. However, the longer lifespan of
common marmosets compared with rodents may result in an extended period for in vivo analysis of common
marmoset disease models. Therefore, establishing rapid and efficient techniques for obtaining neuronal cells from
transgenic individuals that enable in vitro analysis of molecular mechanisms underlying diseases are required.
Recently, several groups have reported on methods, termed direct reprogramming, to generate neuronal cells by
defined factors from somatic cells of various kinds of species, including mouse and human. The aim of the present
study was to determine whether direct reprogramming technology was applicable to common marmosets.
Results: Common marmoset induced neuronal (cjiN) cells with neuronal morphology were generated from
common marmoset embryonic skin fibroblasts (cjF) by overexpressing the neuronal transcription factors: ASCL1,
BRN2, MYT1L and NEUROD1. Reverse transcription-polymerase chain reaction of cjiN cells showed upregulation of
neuronal genes highly related to neuronal differentiation and function. The presence of neuronal marker proteins
was also confirmed by immunocytochemistry. Electrical field stimulation to cjiN cells increased the intracellular
calcium level, which was reversibly blocked by the voltage-gated sodium channel blocker, tetrodotoxin, indicating
that these cells were functional. The neuronal function of these cells was further confirmed by electrophysiological
analyses showing that action potentials could be elicited by membrane depolarization in current-clamp mode while
both fast-activating and inactivating sodium currents and outward currents were observed in voltage-clamp mode.
The 5-bromodeoxyuridine (BrdU) incorporation assay showed that cjiN cells were directly converted from cjFs
without passing a proliferative state.
Conclusions: Functional common marmoset neuronal cells can be obtained directly from embryonic fibroblasts by
overexpressing four neuronal transcription factors under in vitro conditions. Overall, direct conversion technology
on marmoset somatic cells provides the opportunity to analyze and screen phenotypes of genetically-modified
common marmosets.
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The common marmoset (Callithrix jacchus) is a New
World primate that has recently attracted considerable
attention as a non-human primate model for biomed-
ical research [1]. Specific features of the common mar-
moset are its small size, ease of handling, high fertility,
early sexual maturity, its similarity of physiological
properties with humans, drug metabolism, and neuro-
physiological functions [1]. Thus far, transgenic mice
modeling human neurodegenerative diseases have con-
tributed to disease research and drug development.
However, none of them have succeeded in faithfully re-
capitulating the full spectrum of disease pathologies ob-
served in humans [2,3]. In a recent report by our group,
transgenic marmosets with germline transmission were
successfully generated for the first time by lentiviral
vector-mediated gene transfer [4]. For these reasons,
our novel transgenic non-human primate models may
be suitable for studying human diseases, particularly
those that are neurodegenerative, such as Alzheimer’s
and Parkinson’s disease. These in vivo models are ex-
pected to faithfully recapitulate pathophysiology of hu-
man diseases, and thus provide for the missing link
between mouse and human disease research with sub-
sequent drug development. However, results of studies
from these models may require an extended period be-
cause of the longer lifespan of common marmosets
compared with mice [5]. Moreover, detailed in vitro
analyses using primary neuronal cultures of the affected
area of the common marmoset transgenic models are
not realistic.
Recent studies using human neuronal cells derived
from either pluripotent stem cells or somatic cells have
succeeded in modeling human neurological disorders
in vitro [6,7]. These results prompted us to develop a
convenient and rapid method for obtaining common
marmoset neuronal cells from accessible somatic cells.
Therefore, we focused on somatic cell reprogramming
technology, including induced pluripotent stem (iPS)
cell and direct conversion technology [8,9]. However,
few studies have succeeded in generating common mar-
moset iPS cells from neonatal skin fibroblasts, fetal liver
cells, and adult bone marrow-derived cells [10-12]. More-
over, only a few protocols exist for obtaining functional
common marmoset neuronal cells from pluripotent stem
cells [13]. Furthermore, little attention has been given to
the direct conversion technology of common marmoset
dermal fibroblasts into neuronal cells thus far. Therefore,
in the present study, we aimed to generate common mar-
moset neuronal cells directly from dermal fibroblasts. Our
results provide the first line of evidence for the generation
of electrophysiologically functional neuronal cells from
common marmoset somatic cells by defined neuronal
transcription factors.Results and discussion
Validation of the lentivirus-mediated overexpression of
neuronal transcription factors
Recently, generation of induced neuronal (iN) cells was
reported using mouse and human dermal cells [9,14]. In
the present study, we used a set of neuronal transcrip-
tion factors for human iN cells on common marmoset
embryonic skin fibroblasts (cjF) isolated from embryonic
day 91 (E91) embryos to determine whether common
marmoset somatic cells could be converted into neur-
onal cells. We first confirmed transgene expression in
the mouse fibroblast cell line, NIH3T3, by infecting
these cells with lentiviral vectors coding the neuronal
transcription factors: ASCL1, BRN2, MYT1L, and NEU-
ROD1 [14], under the control of tetracycline response
element (TRE) together with reverse tetracycline transacti-
vator (rtTA)-expressing vector. Upregulation of transgenes
in NIH3T3 cells after doxycycline (dox) treatment was
confirmed by immunocytochemistry (Additional file 1).
Generation of neuron-like cells from common marmoset
somatic cells
To address whether cjFs, which were immunonegative for
the neural progenitor marker, SRY (sex determining region
Y)-box 2 (Sox2) (data not shown), can be converted into
cjiN cells, cjFs were infected with these lentiviral vectors at
0 day in vitro (div) (Figure 1A). Synapsin reporter-positive
mouse iN cells have been shown to be more functionally
mature than negative cells [15]. Therefore, the reporter
lentivirus, which expresses fluorescent protein (enhanced
green fluorescent protein or DsRed) under the control of
the human synapsin I promoter, was used in the present
study to monitor neuronal conversion of cjFs [16-18]
(Figure 1A). When cjFs were treated with dox at 1 div to
induce neuronal conversion (Figure 1B), synapsin reporter-
positive cells with typical neuronal morphologies were
observed (Figure 2A, B). However, cjFs without dox treat-
ment did not generate synapsin reporter-positive cells
(Figure 2A). Notably, the morphology of synapsin reporter-
positive cells resembled fibroblasts at 9 div and then changed
into neuronal ones during reprogramming (Figure 2A, B).
The reprogramming efficiency was monitored by the
number of synapsin reporter-positive cells with neuronal
morphology, and depended on the concentration of dox
yielding 0.3 ± 0.1, 21.8 ± 0.8, or 32.6 ± 2.6 cjiN cells/cm2 at
16 div when treated with 0, 1, or 2 μg/mL dox, respect-
ively (Figure 2C) (P*** < 0.001, P## < 0.01, n = 4). However,
the overall induction efficiency was much lower (<1%)
than those in previous studies using mouse and human fi-
broblasts [9,14]. This discrepancy was probably due to the
low infection efficiency of lentivirus in cjFs compared with
those in mouse and human fibroblasts. Previous studies
have also shown that polycistronic vector, micro RNAs
and small molecules can facilitate iN cell induction
Figure 1 Schematic overview of the experimental procedure for generation of common marmoset induced neuronal cells from
common marmoset embryonic skin fibroblasts. (A) Common marmoset embryonic skin fibroblasts (cjFs) were infected with drug-inducible
lentiviral vectors coding a set of induced neuronal (iN) cell factors: ASCL1, BRN2, MYT1L, and NEUROD1. Synapsin reporter lentivirus expressing
green fluorescent protein (GFP) or DsRed under the human synapsin I promoter was used to monitor neuronal induction. The lentiviral vector
that stably drives rtTA expression under the EF1α promoter was transduced to induce the expression of iN-factors. (B) Time course for common
marmoset induced neuronal (cjiN) cell induction. Lentivirus infection was conducted at 0 day in vitro (div) in fibroblast medium containing 10%
fetal bovine serum, and cells were exposed to doxycycline (dox) at 1 div for cjiN induction. The culture medium was then replaced at 3 div with
dox-containing neural meium composed of N2B27 medium, neurotrophin-3 (NT-3) and brain-derived neurotrophic factor (BDNF). For calcium
imaging, the cAMP analog, 8-(4-Chlorophenylthio) adenosine 3′, 5′-cyclic monophosphate (8-CPT; 100 μM) [29], was added to promote neuronal
maturation and survival.
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may be optimized in the future study to enhance the con-
version efficiency. Nevertheless, our results show that the
four-factor set of neuronal transcription factors is suffi-
cient to convert cjFs to cjiN cells.
The duration of dox treatment was critical for neuronal
conversion
Next, we investigated the required duration of exogenous
neuronal transcription factor expression to drive neuronal
transdifferentiation. Therefore, we examined the exposure
time of dox and the cjiN induction efficiency (Figure 2D).
Treatment with dox from 1–3 div promoted the conver-
sion of cjFs into synapsin reporter-positive cells with neur-
onal morphology (Figure 2E). Similarly, a previous study
has shown that the endogenous neuronal transcriptional
factor network is activated 48 h after dox treatment [14].
Our findings also revealed that the induction efficiency at
23 div depended on the exposure time of dox (Figure 2F).
The treatment of cjFs with dox from 1–11 div followed bya culture without dox treatment from 11–23 div generated
112.1 ± 28.1 cjiN cells/cm2 (Figure 2F). However, cells cul-
tured with dox from 1–3 div followed by a culture without
dox treatment from 3–23 div generated only 10.6 ± 5.4
cjiN cells/cm2 (Figure 2F). The efficiency of the former
group was significantly (P*** < 0.001, n = 4) higher (more
than 10-fold) compared with the latter group (Figure 2F).
These results indicate that a longer expression of exogen-
ous neuronal transcriptional factors is required for effi-
cient lineage conversion of somatic cells.
cjiN cells expressed a subset of neuronal genes and
proteins
To characterize cjiN cells as neuronal cells, we per-
formed reverse transcription-polymerase chain reaction
(RT-PCR) analysis using bulk RNA samples, including
the remaining synapsin reporter-negative cells to explore
the expression of neuronal genes (see Table 1 for the pri-
mer sets used). We detected an upregulation of neuronal
genes (Figure 3), which included cytoskeletal markers
Figure 2 Generation of iN cells. (A, B) Transgene-dependent conversion of common marmoset fibroblasts into neuronal cells, in which
synapsin reporter activation and morphological changes were dependent on the exogenous transcription factor and time. Cells became synapsin
reporter-positive accompanied by a gradual morphological changes into neuronal cells, both effects of which were not found in cells cultured in
neural medium without dox at 21 div. (B) Magnified images of Figure 1A showing synapsin reporter-positive cells with morphological changes
from fibroblasts to neuronal cells. (C) Counts of synapsin reporter-positive cells with neuronal morphology showed a dox-dependent increase in
their number (positive cells with fibroblast morphology were excluded from the counts). P*** < 0.001, P## < 0.01 (one-way ANOVA followed by
Tukey’s test). (D-F) The effect of sustained dox treatment on the production of cjiN cells. (D) Cells were treated with dox at 1 div until 3, 5, 7, 9 or
11 div and then maintained without dox until 23 div. (E) Synapsin reporter-positive cells with neuronal morphology were observed in all
treatment group. (F) Cell counts revealed that a longer treatment time of dox increased the number of cjiN cells. Although dox treatment from
1–3 div sufficiently promoted cjiNs, a longer treatment time increased their number. P*** < 0.001 (one-way ANOVA followed by Tukey’s test).
Scale bar; 200 μm.
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and VGLUT1), and cation channel-related genes (SCN1A,
GRIN1 and GRIA1) in cjiN cells at 21 div (Figure 3). How-
ever, expression of these neuronal genes was not detected
in cjFs at 0 div (Figure 3). These results were in line with
the concentration-dependent induction efficiency of doxin Figure 2C. We also detected endogenous expression of
BRN2 and NEUROD1 in cjiN cells at 21 div (Figure 3), in-
dicating that ectopic expression of neuronal transcription
factors activated the endogenous neuronal program. This
effect may have caused neuronal transdifferentiation from
somatic cells [9,14,21]. Thus, ectopic neuronal differentiation
Table 1 Primer sets used in RT-PCR analysis
Gene name Forward primer Reverse primer Product size (bp)
SYN1 acggagactaccgcagtttg cgatctgctccagcattgca 459
DCX ctgtgcgtgtgcttctgaac tcagctggagacttgcttcg 346
TUBB3 catagaccccagtggcaactacg caccctccgtgtagtggcccttgg 241
MAP2 cctgtgttaagcggaaaacc agagactttgtcctttgcctgt 86
VGLUT1 tcaataacagcacgacccac tcccggaatttgagtgacaatg 131
SCN1A attggcaattccgtgggagc cccacacagcacgcggaaca 204
GRIN1 accccaagatcgtcaacatcg ggctaaccagaatggcgtaga 213
GRIA1 cgagctttcctgttgatacat tctgccacttgtaatggtcgatg 99
endo BRN2 aattaaggaaaaaggaaagcaact caaaacatcattacacctgct 71
endo NEUROD1 gttattgtgttgccttagcacttc agtgaaatgaattgctcaaattgt 77
ACTB ggcatccacgaaactaccttt acactgagtacttgcgctcg 202
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neuronal program to efficiently convert non-neuronal
cells into neuronal cells [21].
To further characterize the property of cjiN cells, we per-
formed immunocytochemistry for the neuronal markers.
The results showed that most synapsin reporter-positive
cells also expressed (>88%) the pan-neuronal marker,
microtubule-associated protein 2 (MAP2) (data not shown).
This result indicated that the synapsin reporter using the
sequence of human synapsin I promoter was also func-
tional in common marmoset cells, and was thus a reliable
reporter for neuronal conversion, as previously reported
[15,16]. In cjiN cells at 43 div, MAP2-negative cells were
found to be negative for glial fibrillary acidic protein and
only weakly positive for α-smooth muscle actin (data not
shown), raising the possibility that they were partially
reprogrammed cells. The MAP2- and synapsin reporter-
positive cells also showed immunoreactivity for the synapticFigure 3 Neuronal marker gene expression in cjiN cells. Dox
treatment upregulated cytoskeletal (MAP2, DCX, and TUBB3) and
synaptic vesicular (SYN1 and VGLUT1) marker genes, and cation
channel-related genes (SCN1A, GRIN1 and GRIA1). The results also
showed the activation of endogenous BRN2 and NEUROD1 genes.vesicle marker, synaptophysin, at 38 div (Figure 4A). How-
ever, immunostaining for synaptophysin and PSD95 re-
vealed that these cells were unlikely to make synapse
structures at 38 div (data not shown). Although the cjiN
cells expressed neuronal marker genes and proteins,
they did not appear to be mature enough to make syn-
aptic contacts themselves. However, a future study may
facilitate synaptic formation by improving induction ef-
ficiency and by co-culturing with astrocytes [9,14].
The majority of cjiN cells were glutamatergic
To characterize the neurotransmitter phenotype of iN
cells, we examined the expression of neurotransmitters
in MAP2-positive cjiN cells. Immunostaining at 38 div
for vesicular glutamate transporter 1 (vGlut1) and gamma
aminobutyric acid (GABA) revealed the presence of both
excitatory glutamatergic and inhibitory GABAergic
neuronal cells, respectively (Figure 4B). Counts of
vGlut1 and GABA-positive cjiN cells showed a signifi-
cantly (P*** < 0.001, n = 4) greater number of vGlut1-
positive cells (39.2 ± 1.9/cm2) than GABA-positive cells
(16.4 ± 2.8 cells/cm2) (Figure 4C). These results are in
accordance with previous studies showing that the ma-
jority of iN cells are excitatory cells [7,14,22]. Our find-
ings thus indicate that iN induction may be feasible in
the future for the in vitro analysis of the transgenic
common marmoset model of Alzheimer’s disease, in
which forebrain excitatory neurons are expected to be
affected. Moreover, our cjiN cell induction protocol is
likely advantageous over the previously reported neur-
onal differentiation protocol which used common mar-
moset embryonic stem (ES) cells and iPS cells, because
the ES/iPS cell-derived neural precursor cells showed
caudal identity [13]. Thus far, several groups have suc-
ceeded in generating reprogrammed neuronal cells
with specific neuronal subtypes, such as dopaminergic
neurons and motor neurons [23-26], which implicate the
cell fate plasticity of terminally differentiated somatic cells.
Figure 4 Immunocytochemistry of cjiN cells. (A) Synapsin reporter-positive-cjiN cells expressed microtubule-associated protein 2 (MAP2) and
synaptophysin. (B) cjiN cells were vesicular glutamate transporter 1 (vGlut1)- and gamma-aminobutyric acid (GABA)-positive, thereby displaying a
heterogeneous pool of excitatory and inhibitory neurons, respectively. (C) A significantly greater number of vGlut1-positive cells was generated
compared with GABA-positive cells. P*** < 0.001 (Student’s t-test). Scale bar; 50 μm.
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atic cells into excitatory and inhibitory neuronal cells using
defined iN factors may therefore provide great promise in
the future for generating specific subtypes of neuronal
cells with specific sets of neuronal transcription factors.
cjiN cells were functional as matured neurons
To further confirm the successful conversion of cjFs into
functional neuronal cells, we performed calcium imaging
analysis. cjiN cells cultured with dox were incubated
with the calcium indicator, Fluo-4 AM [13], followed by
response recordings. The intracellular calcium level
([Ca2+]i) in cjiN cells at 15 div was increased in cjiN cells
perfused with 80 mM of KCl, which was then decreased
by washout (Additional file 2). Furthermore, electrical
field stimulation on cjiN cells at 28 div increased [Ca2+]i,
which was reversibly blocked by the voltage-gated so-
dium channel blocker, tetrodotoxin (0.2 μM) (Figure 5),
suggesting that the increase in [Ca2+]i was likely evoked
by action potentials through voltage-gated sodium chan-
nels. These results showed that cjiN cells derived from
cjFs were functionally comparable to common marmoset
ES cell-derived neuronal cells [13], and thus strongly sug-
gest that reprogramming of common marmoset somaticFigure 5 Increase in the intracellular calcium level upon electrical fiel
morphology). (B, C) Intracellular calcium level ([Ca2+]i) in cjiN cells was mea
(40 Hz for 5 seconds) induces a robust elevation of [Ca2+]i in some synapsin r
the specific voltage-gated sodium channel blocker, tetrodotoxin. Scale bar; 50cells generates functional neuronal cells. Moreover,
electrophysiological analyses of cjiN cells at 29–42 div
revealed that action potentials were elicited by mem-
brane depolarization in current-clamp mode in 17 out
of 21 cjiN cells (81.0%) (Figure 6A and Additional file 3).
Among these 17 cjiN cells, 7 cjiN cells (41.2%) generated
a single action potential and the remaining 10 cjiN cells
(58.8%) generated repetitive action potentials (Figure 6A
and Additional file 3). In the voltage-clamp mode, both
fast-activating and inactivating sodium currents and out-
ward currents were observed (Figure 6B). The resting
membrane potentials of cjiN cells ranged between -26
and -55 mV, with a mean ± SEM of -38.1 ± 2.0 mV
(Figure 6C and Additional file 3). This mean value was sig-
nificantly (P*** < 0.001) lower than that of cjFs (-16.4 ±
0.6 mV) with a range between -13.1 and -19.0 mV
(Figure 6C and Additional file 3). Overall, our patch
clamp recordings showed that cjiN cells are functional
neuronal cells.
cjiN cells were directly converted from cjFs without
passing through a proliferative state
To determine whether cjiN cells were directly converted
from cjFs without passing through a proliferative neurald stimulation. (A) cjiN cells (synapsin reporter-positive with a neuronal
sured by the intensity of Fluo-4 fluorescence. Electrical field stimulation
eporter-positive cells. The increase in [Ca2+]i was reversibly suppressed by
μm.
Figure 6 Neuronal electrophysiological property of cjiN cells. (A) cjiN cells elicited repetitive action potential by membrane depolarization in
current-clamp mode. (B) cjiN cells showed both fast-activating and inactivating sodium currents and outward currents in voltage-clamp mode.
(C) cjiN cells exhibited significantly lower resting membrane potentials than cjFs. P*** < 0.001 (Mann-Whitney U-test).
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10 μM) was added to the media at 1, 3 or 5 div until 24
div (Figure 7A), and the percentage of double-positive
cells for BrdU and MAP2 among the MAP2 single-
positive cells was determined (Figure 7B, C). The result
showed that while 85.3 ± 5.4% of MAP2-positive cells in-
corporated BrdU when treated from 1–24 div, only 30.1 ±
9.0% (P** < 0.01) and 1.5 ± 1.5% (P*** < 0.001) of MAP2-
positive cells incorporated BrdU when treated from 3–24
and 5–24 div, respectively (Figure 7C). This result indi-
cates that most of the cells that were destined to be cjiN
cells became postmitotic at the early phase of the repro-
gramming process, suggesting that cjiN induction is a dir-
ect process unless cells pass through a proliferative neuralFigure 7 Cells destined to be cjiN cells became postmitotic at the ear
BrdU incorporation experiment. BrdU (10 μM) was added into the culture m
Immunocytochemistry against MAP2 and BrdU revealed that when cells we
were BrdU +MAP2+, while when treated at 3 or 5 div until 24 div, only 30.
showing that the cjFs became postmitotic soon after transgene expressionprogenitor-like cell state, from which neuronal cells can
be differentiated. In the present study, however, no Sox2-
positive cells were found during 2–5 div, while MAP2-
positive cells were present at 21 div (data not shown),
indicating that the induction of neural progenitor-like
cells is unlikely during 1-5 div. Therefore, these results
show that cjiN cells are directly converted from cjFs
without passing through proliferative neural progenitor
cells.
Conclusions
In the present study, we established an in vitro method to
convert common marmoset somatic cells into functional
neuronal (i.e. cjiN) cells. The majority of the cjiN cells werely phase of the reprogramming process. (A) Time course for the
edium at 1, 3 or 5 div until cells were fixed at 24 div. (B, C)
re treated with BrdU at 1 div until 24 div, 85.2 ± 5.4% of cjiN cells
1 ± 9.0% or 1.5 ± 1.5% of cjiN cells were BrdU +MAP2+, respectively,
. P*** < 0.001 P** < 0.01. Scale bar; 50 μm.
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neuronal marker genes: TUBB3, DCX, MAP2, SYN1,
VGLUT1, SCN1A, GRIN1 and GRIA1. Importantly, cjF-
derived cjiN cells exhibited functional neuronal properties
and responded to exogenous stimulation. Overall, these
findings suggest that direct conversion technology may be
beneficial in rapid and robust screening of neuronal
phenotypes of transgenic common marmoset models of




All animal experiments were approved by the Institu-
tional Animal Care and Use Committee of the Central
Institute for Experimental Animals (CIEA), and was per-
formed in accordance with CIEA and Keio University
guidelines.
Cell culture
Common marmoset embryonic fibroblasts, NIH3T3 cells
and 293T cells were cultured in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal bovine
serum, 100 U/mL of penicillin and 100 μg/mL of strepto-
mycin (10% FP medium) at 37°C with 5% CO2 incubation.
Molecular cloning and lentivirus production
cDNA entry clone of human ASCL1 [GenBank: NM_004316]
was purchased from DNAFORM (clone ID: 100006383,
Japan). cDNAs of human BRN2 [GenBank: NM_0056
04.3], MYT1L [GenBank: NM_015025.2] and NEUROD1
[GenBank: NM_002500.4] were cloned into pENTR-D-
TOPO vector (Invitrogen, USA). Then cDNAs were
inserted into a self-inactivation human immunodeficiency
virus-1-based lentivirus construct, CSIV-TRE-RfA (CSIV-
TRE-RfA-CMV-KT was kindly provided by Dr. Hiroyuki
Miyoshi (RIKEN BRC, Japan), and then modified by Dr.
Takuji Maeda (Nagoya University, Japan)), by LR reaction
(Invitrogen, USA). Similarly, reverse tetracycline trans-
activator (rtTA) gene was inserted into CSII-EF1α-RfA-
TK-HygR construct [27]. The human synapsin I reporter
constructs, pCSC-hSynI-GFP [16] and pHIV7-hSynI-
DsRed [18], were kindly provided by Dr. Fred H. Gage,
Salk Institute, USA, and Dr. Alysson R. Muotri, University
of California, USA, respectively. Besides, CSIV-hSynI-GFP-
IRES2-NeoR and CSIV-hSynI-DsRed-IRES2-NeoR were
constructed in-house. These reporters were constructed
using CSIV-TRE-RfA-CMV-KT, pCSC-hSynI-GFP, pHIV7-
hSynI-DsRed and pIRESneo3 (Clontech, USA) with PCR-
and restriction enzyme-based method. For lentivirus
production, 293T cells were transfected with lentivirus plas-
mid, pCAG-HIVgp and pCMV-VSV-G-RSV-Rev [28]
(kindly provided by Dr. Hiroyuki Miyoshi, RIKEN BRC,
Japan). After 16-20 h, supernatant was replaced by freshmedia followed by 48-72 h incubation. The virus containing
media were then collected and 0.45 μm-filterated followed
by ultracentrifugation. The concentrated virus was sus-
pended in PBS and used in subsequent experiments.
Induction of common marmoset iN cells
Common marmoset embryonic fibroblasts were seeded
directly on culture ware at 1 × 104 cells/cm2. Twenty-four
hours later, the cells were infected with lentivirus in 10%
FP media containing polybrene (8 μg/mL) (Sigma-Aldrich,
USA). After 16–20 h in media containing lentivirus, the
cells were switched into fresh 10% FP medium containing
doxycycline (dox) (2 μg/mL) to drive transgene expres-
sion. Procedures for experiments determining the suffi-
cient concentration and duration of dox are shown in
the main text. After 48 h in 10% FP media with dox, the
media was replaced with dox-containing neural media
composed of N2B27 media [20], brain-derived neuro-
trophic factor (BDNF) (10 ng/mL, R&D systems, USA)
and neurotrophin-3 (NT-3) (10 ng/mL, R&D systems,
USA). For calcium imaging, 8-(4-Chlorophenylthio) ad-
enosine 3′, 5′-cyclic monophosphate (8-CPT, 100 μM,
Sigma-Aldrich, USA), one of the cAMP analogs [29],
was also supplemented to promote neuronal matur-
ation. The media was changed every 2–3 days during
culture period. BrdU incorporation assay was performed
as previously described [9] incubating cells with BrdU
(10 μΜ, BD, USA) until cells were fixed.
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde for 15 mi-
nutes at room temperature and then processed for im-
munocytochemistry [13]. Samples were rinsed with PBS
three times. Then, samples were incubated at 4°C over-
night with the primary antibodies diluted in PBS con-
taining 5% of fetal bovine serum and 0.3% Triton X-100.
The primary antibodies used were as follows; Synapto-
physin (1:50000, Millipore, USA), MAP2 (1:1000, Sigma-
Aldrich, USA), MAP2 (1:500, Millipore, USA), vGlut1
(1:2000, Synaptic systems, Germany), GABA (1:1000,
Sigma-Aldrich, USA), PSD95 (1:500, Millipore, USA), α-
SMA (1:500, Sigma-Aldrich, USA), Sox2 (1:500, R&D,
USA), Ascl1 (1:200, BD, USA), Brn2 (1:200, Santa Cruz,
USA), Myt1L (1:500, Abcam, England) and NeuroD1 (1:500,
Santa Cruz, USA). After three washes with PBS, samples
were incubated with secondary antibodies conjugated with
Alexa-488, Alexa-555 and Alexa-647 (Invitrogen, USA).
Nuclei were counterstained with 4’, 6-diamidino-2-pheny-
lindole (DAPI; 1:1000, Dojindo, Japan). After washing with
PBS, samples were mounted on slides with FluorSave re-
agent (Calbiochem, Germany) and examined under a uni-
versal fluorescence microscope (Axioplan 2; Carl Zeiss,
Germany). For anti-BrdU staining (1:500, Abcam, England),
cells were treated with 1 N HCl in PBS for 30 minutes at
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antibody incubation.
RNA isolation and reverse transcription-polymerase chain
reaction (RT-PCR)
Total RNA was isolated with RNeasy Micro Kit with
DNase I treatment (QIAGEN, Germany) and was used
to synthesize cDNA with ReverTraAce qPCR RT Kit
(TOYOBO, Japan) according to the manufacturer’s in-
struction. RT-PCR was conducted using Ex Taq HS
(TAKARA, Japan) according to the manufacturer’s instruc-
tion. Common marmoset ES (cjES) cells and cjES-derived
neurons were used as control [13]. The primer sets used
are listed in Table 1.
Calcium imaging and electrical stimulation
Calcium imaging analyses were performed as described
previously [13]. To load the calcium imaging dye, cells
were incubated with 1 μM Fluo-4 AM (Invitrogen, USA)
in imaging solution consisting of 117 mM NaCl, 2.5 mM
KCl, 2 mM CaCl2, 2 mM MgSO4, 25 mM HEPES and
30 mM D-(+)-glucose, (pH 7.4), at 37°C for 20 minutes,
followed by washing for 30 minutes in imaging solution.
Coverslips were placed on a custom-made field stimula-
tion chamber and mounted on the stage of a Nikon
Eclipse microscope with a 20× (NA 0.45) objective. Cells
were perfused at 2 ml/minute with the imaging solution
at room temperature with or without 0.2 μM tetrodo-
toxin (TTX; Alomone Labs Ltd., Israel). Images were
acquired at 2 Hz (500 millisecond exposure time) with
a cooled CCD camera (Andor iXon, DU897). Extracel-
lular field stimulation was performed with two parallel
platinum wires at 25 V/cm. Each stimulation was a
train of 500 microsecond pulses at 40 Hz for 5 seconds.
Images were analyzed with ImageJ software (NIH,
Bethesda, MD).
Electrophysiology
Electrophysiological recordings were performed as de-
scribed previously [30]. Synapsin reporter-positive cjiN
cells were identified under an inverted microscope (Dia-
phot-TMD 200; Nikon, Japan) and whole cell patch clamp
recordings were done using Axopatch 200B (Axon Instru-
ments, USA) at room temperature. The extracellular solu-
tion composed of 117 mM NaCl, 2.5 mM KCl, 2 mM
CaCl2, 2 mM MgCl2, 15 mM D-Glucose and 20 mM
HEPES (pH 7.4 adjusted with NaOH, 304 mOsm) was
continuously perfused during recordings. Patch pipettes
had a resistance of 5-6 MΩ filled with the intracellular so-
lution containing 130 mM K-gluconate, 1 mM CaCl2,
1 mM MgCl2, 10 mM EGTA, 10 mM Sucrose and 20 mM
HEPES (pH adjusted with KOH, 305 mOsm). In
voltage-clamp recordings, iN cells were held at -70 mV
and voltage steps (10 mV, 300 msec) were applied to elicitvoltage-activated currents. Action potentials were evoked
by injecting step currents (20-40 pA, 500 msec) in the
current-clamp mode. Data were digitized at 10 kHz
with a 2 kHz low-pass filter. Liquid junction potential
was corrected.Statistical analysis
All data were expressed as means ± SEM. The statistical
significance of differences was analyzed by Student’s t-test,
Mann-Whitney U-test or one-way ANOVA followed by
Tukey’s test using Graph Pad Prism5 software. Differences
of P < 0.05 were considered statistically significant.Additional files
Additional file 1: Doxycycline-dependent transgene induction in
NIH3T3 cells. Immunocytochemistry against Ascl1, Brn2, Myt1L and
NeuroD1 in a mouse fibroblast cell line, NIH3T3 cells, that were lentivirally
transduced with iN factors and treated with doxycycline from 1–4 div
revealed doxycycline-dependent transgene expressions. Scale bar;
100 μm.
Additional file 2: KCl perfusion increased the intracellular calcium
level. (A) cjiN cells (synapsin reporter-positive with a neuronal
morphology). (B, C) Intracellular calcium level ([Ca2+]i) in cjiN cells was
measured by the intensity of Fluo-4 fluorescence. KCl (80 mM) perfusion
caused a robust elevation of [Ca2+]i in some synapsin reporter-positive
cells. This increase was reversibly suppressed by washout. Scale bar;
50 μm.
Additional file 3: Electrophysiological parameters in cjiN cells at
29–42 div.Abbreviations
cjiN cells: Common marmoset induced neuronal cells; cjF: Common
marmoset embryonic fibroblast; RT-PCR: Reverse transcription-polymerase
chain reaction; dox: Doxycycline; rtTA: Reverse tetracycline transactivator.
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